Phreesia, Inc. $PHR Stake Boosted by SG Americas Securities LLC

SG Americas Securities LLC grew its position in Phreesia, Inc. (NYSE:PHR) by 544.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 457,925 shares of the company’s stock after purchasing an additional 386,848 shares during the period. SG Americas Securities LLC’s holdings in Phreesia were worth $3,837,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Van ECK Associates Corp increased its holdings in Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after buying an additional 1,102 shares during the last quarter. Rockefeller Capital Management L.P. lifted its stake in Phreesia by 354.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after acquiring an additional 2,149 shares during the last quarter. KBC Group NV grew its position in Phreesia by 83.4% in the fourth quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after acquiring an additional 1,568 shares in the last quarter. Garner Asset Management Corp bought a new stake in Phreesia in the fourth quarter worth approximately $81,000. Finally, Anchor Investment Management LLC acquired a new position in shares of Phreesia during the 3rd quarter worth $118,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia’s most recently reported quarter topped analyst expectations on both earnings and revenue, with year-over-year revenue growth of 12.9%, reinforcing the view that the business is still growing. Phreesia stock and earnings background
• Neutral Sentiment: Several law firms, including Rosen, Faruqi & Faruqi, Schall, DJS, Howard G. Smith, and Bronstein, Gewirtz & Grossman, issued deadline reminders and plaintiff solicitations related to a securities class action against Phreesia, with the lead-plaintiff deadline set for July 13, 2026. Phreesia lawsuit deadline article
• Negative Sentiment: The class-action allegations create legal overhang for Phreesia, which can weigh on investor confidence as shareholders assess potential liability, distraction, and reputational risk. Phreesia securities lawsuit article
• Negative Sentiment: News also highlighted insider selling by a Phreesia director, which may add pressure by signaling reduced insider conviction. Phreesia insider selling article

Insiders Place Their Bets

In other news, insider David Linetsky sold 8,332 shares of the firm’s stock in a transaction on Friday, April 10th. The shares were sold at an average price of $8.07, for a total value of $67,239.24. Following the sale, the insider owned 224,056 shares in the company, valued at approximately $1,808,131.92. This trade represents a 3.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Yvonne Hui sold 10,063 shares of the business’s stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $9.08, for a total transaction of $91,372.04. Following the transaction, the insider directly owned 25,991 shares in the company, valued at $235,998.28. This trade represents a 27.91% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 42,927 shares of company stock valued at $368,022 in the last three months. Company insiders own 5.20% of the company’s stock.

Phreesia Trading Up 1.9%

NYSE:PHR opened at $10.27 on Tuesday. The company’s 50 day moving average is $9.38 and its 200-day moving average is $11.90. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41. Phreesia, Inc. has a 12 month low of $7.77 and a 12 month high of $32.76. The firm has a market cap of $634.48 million, a price-to-earnings ratio of 68.43 and a beta of 0.91.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. The business had revenue of $130.94 million during the quarter, compared to the consensus estimate of $130.08 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. Phreesia’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.07) EPS. Equities analysts anticipate that Phreesia, Inc. will post 0.35 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently weighed in on PHR shares. Truist Financial raised their price target on shares of Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a report on Thursday, May 28th. Wall Street Zen raised shares of Phreesia from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Robert W. Baird reissued a “neutral” rating and set a $10.00 target price (down from $25.00) on shares of Phreesia in a research report on Tuesday, March 31st. Citizens Jmp restated a “market perform” rating on shares of Phreesia in a report on Wednesday, April 1st. Finally, Needham & Company LLC reduced their price target on Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, March 31st. Nine equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $16.65.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.